The Company operates eight established franchise locations offering a broad portfolio of direct-access lab testing services. Lab test offerings include general wellness panels, nutritional and sexual health screenings, DNA/paternity testing, and comprehensive drug testing solutions. Positioned in high-growth markets with scalable infrastructure and strong brand recognition, the Company serves both consumer and B2B segments.

Key Aspects
· The Company delivered a strong average adjusted EBITDA margin of 18.3% from 2023 to 2025, reflecting operational efficiency and healthy unit-level economics.
· The Company holds exclusive franchise rights across four key counties in a rapidly growing metropolitan area, offering protected territorial upside.
· Standardized processes and centralized oversight across all eight locations enable seamless scalability and consistent service delivery.
· The Company utilizes a user-friendly, cloud-based platform for centralized reporting, customer profile management, and operational visibility, which supports multi-site efficiency and customer satisfaction.
· In 2025, the Company launched a national employer account program for drug and alcohol testing, enabling coast-to-coast service delivery that significantly expands B2B revenue opportunity.

Opportunities
· Expand high-margin health and wellness lab testing services to capitalize on accelerating consumer demand for preventative, self-directed healthcare solutions.
· Capitalize on growing demand for advanced diagnostics, brain health and cognitive testing, and preventative wellness services.
· Expanding market opportunity in longevity-focused wellness, genetic testing, and regenerative wellness injections.
· Forge strategic alliances with digital health and telemedicine platforms to serve as their core diagnostic lab testing provider, creating recurring referral pipelines and scalability.
· Grow B2B revenue by expanding drug testing services related to the Company’s national and local TPA Consortium offering, strengthening value-added compliance solutions for employers and capitalizing on DOT and regulatory testing mandates.

Headquartered
· Southwest US

Current Markets
· The Company offers direct-access medical lab testing, drug testing, and DNA/paternity testing to individuals and businesses in a Southwester metropolitan area.
· Additionally, employer drug testing solutions are offered nationwide.

Real Estate
· The Company operates from eight facilities, all of which are 890-1,542 sq. ft., in a metropolitan area in the Southwest US. All operating facilities are leased from unrelated third parties and the leases are assumable by new ownership post-sale.

Shareholder Objectives
· The Company is equally owned by a husband and wife team. Owners are open to a negotiable transition period prior to an eventual full exit and would consider a variety of deal structures to facilitate a transaction.